▶ 調査レポート

馬インフルエンザワクチンの世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Equine Influenza Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。馬インフルエンザワクチンの世界市場 2020年:メーカー別、地域別、種類・用途別 / Global Equine Influenza Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D005-06146資料のイメージです。• レポートコード:D005-06146
• 出版社/出版日:GlobalInfoResearch / 2020年5月
• レポート形態:英文、PDF、109ページ
• 納品方法:Eメール(納期2~3日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥379,320 (USD3,480)▷ お問い合わせ
  Multi User¥568,980 (USD5,220)▷ お問い合わせ
  Corporate User¥758,640 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、馬インフルエンザワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。馬インフルエンザワクチンの種類別市場規模(液体、粉末)、用途別市場規模(ホーム、ペットクリニック、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Zoetis、Merck Animal Health、Boehringer Ingelheim Vetmedica
・地域別グローバル市場分析 2015年-2020年
・馬インフルエンザワクチンの北米市場(アメリカ、カナダ、メキシコ)
・馬インフルエンザワクチンのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・馬インフルエンザワクチンのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・馬インフルエンザワクチンの南米市場(ブラジル、アルゼンチン)
・馬インフルエンザワクチンの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:液体、粉末
・用途別分析:ホーム、ペットクリニック、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Equine Influenza Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Equine Influenza Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Equine Influenza Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Equine Influenza Vaccine market has been segmented into
Liquid
Powder

By Application, Equine Influenza Vaccine has been segmented into:
Home
Pet Clinic
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Equine Influenza Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Equine Influenza Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Equine Influenza Vaccine market.

The report offers in-depth assessment of the growth and other aspects of the Equine Influenza Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Equine Influenza Vaccine Market Share Analysis
Equine Influenza Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Equine Influenza Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Equine Influenza Vaccine sales, revenue and market share for each player covered in this report.

The major players covered in Equine Influenza Vaccine are:
Zoetis
Merck Animal Health
Boehringer Ingelheim Vetmedica

Among other players domestic and global, Equine Influenza Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Equine Influenza Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Equine Influenza Vaccine, with price, sales, revenue and global market share of Equine Influenza Vaccine in 2018 and 2019.
Chapter 3, the Equine Influenza Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Equine Influenza Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Equine Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Equine Influenza Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Equine Influenza Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Equine Influenza Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Liquid
1.2.3 Powder
1.3 Market Analysis by Application
1.3.1 Overview: Global Equine Influenza Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Home
1.3.3 Pet Clinic
1.3.4 Other
1.4 Overview of Global Equine Influenza Vaccine Market
1.4.1 Global Equine Influenza Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Zoetis
2.1.1 Zoetis Details
2.1.2 Zoetis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Zoetis SWOT Analysis
2.1.4 Zoetis Product and Services
2.1.5 Zoetis Equine Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck Animal Health
2.2.1 Merck Animal Health Details
2.2.2 Merck Animal Health Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck Animal Health SWOT Analysis
2.2.4 Merck Animal Health Product and Services
2.2.5 Merck Animal Health Equine Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Boehringer Ingelheim Vetmedica
2.3.1 Boehringer Ingelheim Vetmedica Details
2.3.2 Boehringer Ingelheim Vetmedica Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Boehringer Ingelheim Vetmedica SWOT Analysis
2.3.4 Boehringer Ingelheim Vetmedica Product and Services
2.3.5 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Equine Influenza Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Equine Influenza Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Equine Influenza Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Equine Influenza Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Equine Influenza Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Equine Influenza Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Equine Influenza Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Equine Influenza Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Equine Influenza Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Equine Influenza Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Equine Influenza Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Equine Influenza Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Equine Influenza Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
6.4 France Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Equine Influenza Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Equine Influenza Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Equine Influenza Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
7.5 India Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Equine Influenza Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Equine Influenza Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Equine Influenza Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Equine Influenza Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Equine Influenza Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Equine Influenza Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Equine Influenza Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Equine Influenza Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Equine Influenza Vaccine Price by Type (2015-2020)
11 Global Equine Influenza Vaccine Market Segment by Application
11.1 Global Equine Influenza Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Equine Influenza Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Equine Influenza Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Equine Influenza Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Equine Influenza Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Equine Influenza Vaccine Market Forecast (2021-2025)
12.2.2 Europe Equine Influenza Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Equine Influenza Vaccine Market Forecast (2021-2025)
12.2.4 South America Equine Influenza Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Equine Influenza Vaccine Market Forecast (2021-2025)
12.3 Equine Influenza Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Equine Influenza Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Equine Influenza Vaccine Market Share Forecast by Type (2021-2025)
12.4 Equine Influenza Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Equine Influenza Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Equine Influenza Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Equine Influenza Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Equine Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Equine Influenza Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Zoetis Basic Information, Manufacturing Base and Competitors
Table 8. Zoetis Equine Influenza Vaccine Major Business
Table 9. Zoetis Equine Influenza Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. Zoetis SWOT Analysis
Table 11. Zoetis Equine Influenza Vaccine Product and Services
Table 12. Zoetis Equine Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 14. Merck Animal Health Equine Influenza Vaccine Major Business
Table 15. Merck Animal Health Equine Influenza Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. Merck Animal Health SWOT Analysis
Table 17. Merck Animal Health Equine Influenza Vaccine Product and Services
Table 18. Merck Animal Health Equine Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Boehringer Ingelheim Vetmedica Basic Information, Manufacturing Base and Competitors
Table 20. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Major Business
Table 21. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. Boehringer Ingelheim Vetmedica SWOT Analysis
Table 23. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Product and Services
Table 24. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Global Equine Influenza Vaccine Sales by Manufacturer (2018-2019) (K Doses)
Table 26. Global Equine Influenza Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 27. Global Equine Influenza Vaccine Sales by Regions (2015-2020) (K Doses)
Table 28. Global Equine Influenza Vaccine Sales Market Share by Regions (2015-2020)
Table 29. Global Equine Influenza Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 30. North America Equine Influenza Vaccine Sales by Countries (2015-2020) (K Doses)
Table 31. North America Equine Influenza Vaccine Sales Market Share by Countries (2015-2020)
Table 32. North America Equine Influenza Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 33. North America Equine Influenza Vaccine Revenue Market Share by Countries (2015-2020)
Table 34. Europe Equine Influenza Vaccine Sales by Countries (2015-2020) (K Doses)
Table 35. Europe Equine Influenza Vaccine Sales Market Share by Countries (2015-2020)
Table 36. Europe Equine Influenza Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 37. Asia-Pacific Equine Influenza Vaccine Sales by Regions (2015-2020) (K Doses)
Table 38. Asia-Pacific Equine Influenza Vaccine Sales Market Share by Regions (2015-2020)
Table 39. Asia-Pacific Equine Influenza Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 40. South America Equine Influenza Vaccine Sales by Countries (2015-2020) (K Doses)
Table 41. South America Equine Influenza Vaccine Sales Market Share by Countries (2015-2020)
Table 42. South America Equine Influenza Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 43. South America Equine Influenza Vaccine Revenue Market Share by Countries (2015-2020)
Table 44. Middle East & Africa Equine Influenza Vaccine Sales by Countries (2015-2020) (K Doses)
Table 45. Middle East & Africa Equine Influenza Vaccine Sales Market Share by Countries (2015-2020)
Table 46. Middle East & Africa Equine Influenza Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 47. Middle East & Africa Equine Influenza Vaccine Revenue Market Share by Countries (2015-2020)
Table 48. Global Equine Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 49. Global Equine Influenza Vaccine Sales Share by Type (2015-2020)
Table 50. Global Equine Influenza Vaccine Revenue by Type (2015-2020) (USD Million)
Table 51. Global Equine Influenza Vaccine Revenue Share by Type (2015-2020)
Table 52. Global Equine Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 53. Global Equine Influenza Vaccine Sales Share by Application (2015-2020)
Table 54. Global Equine Influenza Vaccine Sales Forecast by Regions (2021-2025) (K Doses)
Table 55. Global Equine Influenza Vaccine Market Share Forecast by Regions (2021-2025)
Table 56. Global Equine Influenza Vaccine Sales Forecast by Type (2021-2025) (K Doses)
Table 57. Global Equine Influenza Vaccine Market Share Forecast by Type (2021-2025)
Table 58. Global Equine Influenza Vaccine Sales Forecast by Application (2021-2025)
Table 59. Global Equine Influenza Vaccine Market Share Forecast by Application (2021-2025)
Table 60. Direct Channel Pros & Cons
Table 61. Indirect Channel Pros & Cons
Table 62. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Equine Influenza Vaccine Picture
Figure 2. Global Sales Market Share of Equine Influenza Vaccine by Type in 2019
Figure 3. Liquid Picture
Figure 4. Powder Picture
Figure 5. Equine Influenza Vaccine Sales Market Share by Application in 2018
Figure 6. Home Picture
Figure 7. Pet Clinic Picture
Figure 8. Other Picture
Figure 9. Global Equine Influenza Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Equine Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Equine Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Equine Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Equine Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Equine Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Equine Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Equine Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Equine Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Equine Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Equine Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Equine Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Equine Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Equine Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Equine Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Equine Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Equine Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Equine Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Equine Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Equine Influenza Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Equine Influenza Vaccine Sales Market Share by Manufacturer in 2019
Figure 30. Global Equine Influenza Vaccine Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Equine Influenza Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Equine Influenza Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Equine Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 35. Global Equine Influenza Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Equine Influenza Vaccine Revenue Market Share by Regions (2015-2020)
Figure 37. Global Equine Influenza Vaccine Revenue Market Share by Regions in 2018
Figure 38. North America Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Europe Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
Figure 41. South America Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Equine Influenza Vaccine Sales and Growth Rate (2015-2020)
Figure 43. North America Equine Influenza Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Equine Influenza Vaccine Sales Market Share by Countries (2015-2020)
Figure 45. North America Equine Influenza Vaccine Sales Market Share by Countries in 2018
Figure 46. North America Equine Influenza Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Equine Influenza Vaccine Revenue Market Share by Countries in 2018
Figure 48. United States Equine Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 49. Canada Equine Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 50. Mexico Equine Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 51. Europe Equine Influenza Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Equine Influenza Vaccine Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Equine Influenza Vaccine Revenue Market Share by Countries in 2019
Figure 54. Germany Equine Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 55. UK Equine Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 56. France Equine Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 57. Russia Equine Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 58. Italy Equine Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 59. Asia-Pacific Equine Influenza Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Equine Influenza Vaccine Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Equine Influenza Vaccine Revenue Market Share by Regions 2019
Figure 62. China Equine Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 63. Japan Equine Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 64. Korea Equine Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 65. India Equine Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 66. Southeast Asia Equine Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 67. South America Equine Influenza Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Equine Influenza Vaccine Sales Market Share by Countries in 2019
Figure 69. South America Equine Influenza Vaccine Revenue Market Share by Countries in 2019
Figure 70. Brazil Equine Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 71. Argentina Equine Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 72. Middle East and Africa Equine Influenza Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Equine Influenza Vaccine Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Equine Influenza Vaccine Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Equine Influenza Vaccine Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Equine Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 77. Egypt Equine Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 78. Turkey Equine Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 79. South Africa Equine Influenza Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 80. Global Equine Influenza Vaccine Sales and Growth Rate (2021-2025) (K Doses)
Figure 81. Global Equine Influenza Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Equine Influenza Vaccine Market Forecast (2021-2025) (K Doses)
Figure 83. Europe Sales Equine Influenza Vaccine Market Forecast (2021-2025) (K Doses)
Figure 84. Asia-Pacific Sales Equine Influenza Vaccine Market Forecast (2021-2025) (K Doses)
Figure 85. South America Sales Equine Influenza Vaccine Market Forecast (2021-2025) (K Doses)
Figure 86. Middle East & Africa Sales Equine Influenza Vaccine Market Forecast (2021-2025) (K Doses)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel